UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Tumor BRCA testing can reveal a high tumor mutational burden related to POLE pathogenic variants

Gynecologic oncology reports, 2021-08, Vol.37, p.100855-100855, Article 100855

2021

Volltextzugriff (PDF)

Profil clinique et biologie des patients avec mutation du gène CYP24A1 (24 hydroxylase)

Annales d'endocrinologie, 2013-09, Vol.74 (4), p.284-284

2013

Volltextzugriff (PDF)

Hypercalciurie par mutation de CYP24A1 : une pathologie probablement sous-estimée

Annales d'endocrinologie, 2013-09, Vol.74 (4), p.292-292

2013

Volltextzugriff (PDF)

MA03.09 Dramatic Responses to Immune Checkpoint Inhibitors in MET Exon 14 Skipping Mutation (METex14mut) Non Small Cell Lung Cancers

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S259-S259

2019

Volltextzugriff (PDF)

P2.14-53 High MET Overexpression Does Not Predict the Presence of MET Exon 14 Splice Mutations in NSCLC: Results from the IFCT Predict.amm Study

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S851-S851

2019

Volltextzugriff (PDF)

Ultrasensitive detection of EGFR T790M mutation by droplet digital PCR (ddPCR) in TKI naïve non-small cell lung cancer (NSCLC) harboring EGFR mutation: Results of the nationwide program Biomarkers France of the French Cooperative Thoracic Intergroup (IFCT)

Annals of oncology, 2017-09, Vol.28, p.v22-v23

2017

Volltextzugriff (PDF)

Détection de la mutation T790 M par PCR digitale dans une population de cancers bronchiques non à petites cellules (CBNPC) mutés EGFR, avant le traitement par ITK-EGFR : résultats d’une étude ancillaire à l’étude IFCT Biomarqueurs – France

Revue des maladies respiratoires, 2018-01, Vol.35, p.A9-A9

2018

Volltextzugriff (PDF)

ESR1 mutations: a new biomarker in breast cancer

Expert review of molecular diagnostics, 2019-07, Vol.19 (7), p.599-611

2019

Volltextzugriff (PDF)

High-Accuracy Determination of Microsatellite Instability Compatible with Liquid Biopsies

Clinical chemistry (Baltimore, Md.), 2020-04, Vol.66 (4), p.606-613

2020

Volltextzugriff (PDF)

Comprehensive clinical and molecular analyses of neuroendocrine carcinomas of the breast

Modern pathology, 2018-01, Vol.31 (1), p.68-82

2018

Volltextzugriff (PDF)

MSH3 : a confirmed predisposing gene for adenomatous polyposis

Journal of medical genetics, 2023-12, Vol.60 (12), p.1198-1205

2023

Volltextzugriff (PDF)

Multiple Hotspot Mutations Scanning by Single Droplet Digital PCR

Clinical chemistry (Baltimore, Md.), 2018-02, Vol.64 (2), p.317-328

2018

Volltextzugriff (PDF)

Real-Time Detection of ESR1 Mutation in Blood by Droplet Digital PCR in the PADA‑1 Trial: Feasibility and Cross-Validation with NGS

Analytical chemistry (Washington), 2022-04, Vol.94 (16), p.6297-6303

2022

Volltextzugriff (PDF)

Abstract P1-07-01: Real time detection of ESR1 mutation in blood by droplet digital PCR in the PADA-1 trial: Feasibility and cross-validation with NGS

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P1-P1-07-01

2022

Volltextzugriff (PDF)

Abstract 4599: Detecting MSI phenotype in circulating blood DNA

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.4599-4599

2018

Volltextzugriff (PDF)

Hereditary cancer predispositions: Comparison of multigene panel sequencing on fresh‐frozen breast/ovarian tumor versus blood

Clinical genetics, 2023-07, Vol.104 (1), p.107-113

2023

Volltextzugriff (PDF)

Brief report : High MET overexpression does not predict the presence of MET exon 14 splice mutations in NSCLC : results from the IFCT Predict.amm study

Journal of thoracic oncology, 2020-01, Vol.15 (1), p.120-124

2020

Volltextzugriff (PDF)

Abstract 2973: A comprehensive panel of patient-derived xenografts representing the molecular heterogeneity and diversity of triple-negative breast cancer

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.2973-2973

2018

Volltextzugriff (PDF)

Acquired Exon 14 MET Mutation Associated With Resistance to Alectinib in a Patient With ALK-Rearranged NSCLC

JTO clinical and research reports, 2020, Vol.1 (4), p.100082-100082

2020

Volltextzugriff (PDF)

Long response to immune checkpoint inhibitors in metastatic NSCLC despite EGFR germline mutation. A case report

Lung cancer (Amsterdam, Netherlands), 2022, Vol.174, p.186-187

2022

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(23)
Berichte
(3)

Sprache

Englisch
(23)
Französisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Tumor BRCA testing can reveal a high tumor mutational burden related to POLE pathogenic variants

Profil clinique et biologie des patients avec mutation du gène CYP24A1 (24 hydroxylase)

Hypercalciurie par mutation de CYP24A1 : une pathologie probablement sous-estimée

MA03.09 Dramatic Responses to Immune Checkpoint Inhibitors in MET Exon 14 Skipping Mutation (METex14mut) Non Small Cell Lung Cancers

P2.14-53 High MET Overexpression Does Not Predict the Presence of MET Exon 14 Splice Mutations in NSCLC: Results from the IFCT Predict.amm Study

Ultrasensitive detection of EGFR T790M mutation by droplet digital PCR (ddPCR) in TKI naïve non-small cell lung cancer (NSCLC) harboring EGFR mutation: Results of the nationwide program Biomarkers France of the French Cooperative Thoracic Intergroup (IFCT)

Détection de la mutation T790 M par PCR digitale dans une population de cancers bronchiques non à petites cellules (CBNPC) mutés EGFR, avant le traitement par ITK-EGFR : résultats d’une étude ancillaire à l’étude IFCT Biomarqueurs – France

Tumor mutational burden assessment and standardized bioinformatics approach using custom NGS panels in clinical routine

ESR1 mutations: a new biomarker in breast cancer

High-Accuracy Determination of Microsatellite Instability Compatible with Liquid Biopsies

Comprehensive clinical and molecular analyses of neuroendocrine carcinomas of the breast

MSH3 : a confirmed predisposing gene for adenomatous polyposis

Multiple Hotspot Mutations Scanning by Single Droplet Digital PCR

Real-Time Detection of ESR1 Mutation in Blood by Droplet Digital PCR in the PADA‑1 Trial: Feasibility and Cross-Validation with NGS

Response to mTOR and PI3K inhibitors in enzalutamide-resistant luminal androgen receptor triple-negative breast cancer patient-derived xenografts

Abstract P1-07-01: Real time detection of ESR1 mutation in blood by droplet digital PCR in the PADA-1 trial: Feasibility and cross-validation with NGS

Abstract 4599: Detecting MSI phenotype in circulating blood DNA

Hereditary cancer predispositions: Comparison of multigene panel sequencing on fresh‐frozen breast/ovarian tumor versus blood

Brief report : High MET overexpression does not predict the presence of MET exon 14 splice mutations in NSCLC : results from the IFCT Predict.amm study

Abstract 2973: A comprehensive panel of patient-derived xenografts representing the molecular heterogeneity and diversity of triple-negative breast cancer

Abstract B005: Impact of molecular profiling and ESCAT classification on patient outcome: The experience of Institut Curie Molecular Tumor Board

Acquired Exon 14 MET Mutation Associated With Resistance to Alectinib in a Patient With ALK-Rearranged NSCLC

Long response to immune checkpoint inhibitors in metastatic NSCLC despite EGFR germline mutation. A case report

Aktive Filter

Suchergebnisse filtern